Hogan Lovells, Life Sciences | Chambers USA Profile

About

Provided by Hogan Lovells

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires increasingly creative strategies and integrated solutions that protect and support your business day in and day out.

Regardless of the sector of the health care industry you operate or the maturity of your products, we understand how to bridge the gap between the challenges you face and the outcome you want. From budding startups to multinational enterprises, we've been there before and know how to position you for success.

With more than 500 life sciences and health care lawyers across the globe, we work closely with you and each other to tackle tough issues and difficult-to enter markets - no matter where you are today or want to be tomorrow. And because we know what makes your industry tick, we have a deep understanding of the issues you face - helping you stay ahead of the curve and on top of your opportunities.

Whatever your challenge, wherever the issue, Hogan Lovells has you covered.

Chambers Review

Provided by Chambers

Life Sciences: Regulatory/Compliance - USA - Nationwide

Band 1

What the team is known for

Hogan Lovells enjoys a strong reputation for its roster of regulatory attorneys who offer guidance on compliance, approval processes and contentious engagements with government agencies. The firm has additional expertise in pharmaceutical and medical device product liability proceedings. It also advises on business development, clinical trials, capital markets transactions and strategic partnerships.

View ranking table

Work Highlights

Provided by Hogan Lovells

Hogan Lovells worked with Novartis to secure new chemical entity exclusivity for their product Entresto.

Notable Practitioners

Provided by Chambers

David Fox

Band 1

David Fox is well versed in FDA review procedures for new products and Hatch-Waxman compliance issues. He offers further experience in related intellectual property matters and product life cycle management.

"David has a really unique understanding of the FDA."

View Profile

Philip Katz

Band 3

Philip Katz is a seasoned guide for startups and public companies in the biotech and pharmaceuticals industries, frequently assisting clients in the navigation of FDA and other regulatory frameworks. He is well versed in Hatch-Waxman, orphan drug and biosimilars issues and is adept at representing clients in court and before various regulators.

View Profile

Filter by